Gut microbiome ADP-ribosyltransferases are widespread phage-encoded fitness factors.


Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
08 09 2021
Historique:
received: 21 10 2020
revised: 23 06 2021
accepted: 22 07 2021
pubmed: 18 8 2021
medline: 14 1 2022
entrez: 17 8 2021
Statut: ppublish

Résumé

Bacterial ADP-ribosyltransferases (ADPRTs) have been described as toxins involved in pathogenesis through the modification of host proteins. Here, we report that ADPRTs are not pathogen restricted but widely prevalent in the human gut microbiome and often associated with phage elements. We validated their biochemical activity in a large clinical isolate collection and further examined Bxa, a highly abundant ADPRT in Bacteroides. Bxa is expressed, secreted, and enzymatically active in Bacteroides and can ADP-ribosylate non-muscle myosin II proteins. Addition of Bxa to epithelial cells remodeled the actin cytoskeleton and induced secretion of inosine. Bxa-encoding B. stercoris can use inosine as a carbon source and colonizes the gut to significantly greater numbers than a bxa-deleted strain in germ-free and altered Schaedler flora (ASF) mice. Colonization correlated with increased inosine concentrations in the feces and tissues. Altogether, our results show that ADPRTs are abundant in the microbiome and act as bacterial fitness factors.

Identifiants

pubmed: 34403684
pii: S1931-3128(21)00344-9
doi: 10.1016/j.chom.2021.07.011
pmc: PMC8429246
mid: NIHMS1733866
pii:
doi:

Substances chimiques

Inosine 5A614L51CT
ADP Ribose Transferases EC 2.4.2.-
Myosin Heavy Chains EC 3.6.4.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1351-1365.e11

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK043351
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK097485
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109725
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142784
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests R.J.X. is a consultant to Novartis.

Références

Genes Dev. 2020 Feb 6;:
pubmed: 32040441
Structure. 2008 Jul;16(7):1105-15
pubmed: 18611383
Cell. 2018 Nov 15;175(5):1380-1392.e14
pubmed: 30343895
Cell Host Microbe. 2019 May 8;25(5):668-680.e7
pubmed: 31071294
Microb Drug Resist. 2019 Jan/Feb;25(1):72-79
pubmed: 30142035
Genome Res. 2012 Jun;22(6):1107-19
pubmed: 22434425
Methods Mol Biol. 2018;1813:287-295
pubmed: 30097876
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17621-6
pubmed: 23045666
Nature. 2007 Oct 18;449(7164):804-10
pubmed: 17943116
BMC Microbiol. 2005 Oct 07;5:58
pubmed: 16212653
Nature. 2019 Aug;572(7768):244-248
pubmed: 31367037
Nat Rev Microbiol. 2009 Oct;7(10):693-702
pubmed: 19756008
Nucleic Acids Res. 2019 Jul 2;47(W1):W260-W265
pubmed: 31028399
J Biol Chem. 2010 Apr 30;285(18):13525-34
pubmed: 20181945
Cell Host Microbe. 2019 Feb 13;25(2):285-299.e8
pubmed: 30763538
Trends Biochem Sci. 2008 Nov;33(11):546-56
pubmed: 18815047
Nat Chem Biol. 2018 Feb 14;14(3):236-243
pubmed: 29443986
Nat Commun. 2013;4:2304
pubmed: 23942190
Nat Commun. 2021 Jan 19;12(1):462
pubmed: 33469019
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W244-8
pubmed: 15980461
Cell Host Microbe. 2020 Jan 8;27(1):79-92.e9
pubmed: 31901520
Nucleic Acids Res. 2014 Jan;42(Database issue):D581-91
pubmed: 24225323
Genes Dev. 2020 Mar 1;34(5-6):341-359
pubmed: 32029454
Nature. 2019 May;569(7758):655-662
pubmed: 31142855
Annu Rev Microbiol. 2017 Sep 8;71:281-307
pubmed: 28657883
Nat Rev Microbiol. 2014 Sep;12(9):599-611
pubmed: 25023120
Nat Rev Mol Cell Biol. 2009 Nov;10(11):778-90
pubmed: 19851336
Microbiol Mol Biol Rev. 2004 Sep;68(3):560-602, table of contents
pubmed: 15353570
Mol Microbiol. 2019 Jan;111(1):221-236
pubmed: 30315706
Cell Mol Life Sci. 2008 May;65(9):1347-60
pubmed: 18278577
BMC Biol. 2017 Aug 29;15(1):75
pubmed: 28851366
J Appl Toxicol. 2005 Jan-Feb;25(1):30-8
pubmed: 15669043
PLoS Pathog. 2009 Oct;5(10):e1000626
pubmed: 19834554
Genes Dev. 2020 Mar 1;34(5-6):302-320
pubmed: 32029452
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21
pubmed: 27141966
Toxins (Basel). 2020 Dec 11;12(12):
pubmed: 33322547
Curr Top Microbiol Immunol. 2015;384:3-32
pubmed: 25027823
Appl Environ Microbiol. 1999 Aug;65(8):3287-92
pubmed: 10427008
Nat Med. 2019 Sep;25(9):1442-1452
pubmed: 31477907
Nat Biotechnol. 2014 Aug;32(8):834-41
pubmed: 24997786
Nature. 2018 Sep;561(7724):551-555
pubmed: 30232450
Biotechniques. 1999 May;26(5):824-6, 828
pubmed: 10337469
Toxins (Basel). 2019 Jan 03;11(1):
pubmed: 30609803
Nat Biotechnol. 2021 Jan;39(1):105-114
pubmed: 32690973
Toxins (Basel). 2010 Mar;2(3):310-25
pubmed: 22069586

Auteurs

Eric M Brown (EM)

Center for Computational and Integrative Biology, Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Hugo Arellano-Santoyo (H)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Novartis Institutes for Biomedical Research Inc., Cambridge, MA 02139, USA.

Emily R Temple (ER)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Zachary A Costliow (ZA)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Matthieu Pichaud (M)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Novartis Institutes for Biomedical Research Inc., Cambridge, MA 02139, USA.

A Brantley Hall (AB)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Kai Liu (K)

Center for Computational and Integrative Biology, Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Michael A Durney (MA)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Xiebin Gu (X)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Damian R Plichta (DR)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Clary A Clish (CA)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Jeffrey A Porter (JA)

Novartis Institutes for Biomedical Research Inc., Cambridge, MA 02139, USA.

Hera Vlamakis (H)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Ramnik J Xavier (RJ)

Center for Computational and Integrative Biology, Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: xavier@molbio.mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH